BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23224713)

  • 21. Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer.
    Shapira-Furman T; Serra R; Gorelick N; Doglioli M; Tagliaferri V; Cecia A; Peters M; Kumar A; Rottenberg Y; Langer R; Brem H; Tyler B; Domb AJ
    J Control Release; 2019 Feb; 295():93-101. PubMed ID: 30605703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor effect of fibrin glue containing temozolomide against malignant glioma.
    Anai S; Hide T; Takezaki T; Kuroda J; Shinojima N; Makino K; Nakamura H; Yano S; Kuratsu J
    Cancer Sci; 2014 May; 105(5):583-91. PubMed ID: 24673719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5.
    Fiveash JB; Gillespie GY; Oliver PG; Zhou T; Belenky ML; Buchsbaum DJ
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):507-16. PubMed ID: 18474311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intranasal administration of temozolomide for brain-targeting delivery: therapeutic effect on glioma in rats].
    Li Y; Gao Y; Liu G; Zhou X; Wang Y; Wang Y; Ma L
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 May; 34(5):631-5. PubMed ID: 24849425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temozolomide during and after radiation therapy for WHO grade III gliomas: preliminary report of a prospective multicenter study.
    Kim YH; Park CK; Cho WH; Kim IA; Moon S; Choe G; Park SH; Kim IH; Kim DG; Jung HW; Lee MM; Bae SH; Cha SH; Kim CY
    J Neurooncol; 2011 Jul; 103(3):503-12. PubMed ID: 20862518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
    Jalali R; Raut N; Arora B; Gupta T; Dutta D; Munshi A; Sarin R; Kurkure P
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):113-8. PubMed ID: 19647954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Captopril inhibits Matrix Metalloproteinase-2 and extends survival as a temozolomide adjuvant in an intracranial gliosarcoma model.
    Pinheiro L; Perdomo-Pantoja A; Casaos J; Huq S; Paldor I; Vigilar V; Mangraviti A; Wang Y; Witham TF; Brem H; Tyler B
    Clin Neurol Neurosurg; 2021 Aug; 207():106771. PubMed ID: 34198223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local delivery of a synthetic endostatin fragment for the treatment of experimental gliomas.
    Pradilla G; Legnani FG; Petrangolini G; Francescato P; Chillemi F; Tyler BM; Gaini SM; Brem H; Olivi A; DiMeco F
    Neurosurgery; 2005 Nov; 57(5):1032-40; discussion 1032-40. PubMed ID: 16284573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy.
    Storm PB; Moriarity JL; Tyler B; Burger PC; Brem H; Weingart J
    J Neurooncol; 2002 Feb; 56(3):209-17. PubMed ID: 12061726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When temozolomide alone fails: adding procarbazine in salvage therapy of glioma.
    Huang F; Kavan P; Guiot MC; Markovic Y; Roberge D
    Can J Neurol Sci; 2008 May; 35(2):192-7. PubMed ID: 18574933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme.
    McGirt MJ; Than KD; Weingart JD; Chaichana KL; Attenello FJ; Olivi A; Laterra J; Kleinberg LR; Grossman SA; Brem H; Quiñones-Hinojosa A
    J Neurosurg; 2009 Mar; 110(3):583-8. PubMed ID: 19046047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
    Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
    Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local delivery of interleukin-2 and adriamycin is synergistic in the treatment of experimental malignant glioma.
    Hsu W; Lesniak MS; Tyler B; Brem H
    J Neurooncol; 2005 Sep; 74(2):135-40. PubMed ID: 16193383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth.
    Dong J; Zhou G; Tang D; Chen Y; Cui B; Dai X; Zhang J; Lan Q; Huang Q
    J Cancer Res Clin Oncol; 2012 Dec; 138(12):2079-84. PubMed ID: 22825126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models.
    Ewend MG; Williams JA; Tabassi K; Tyler BM; Babel KM; Anderson RC; Pinn ML; Brat DJ; Brem H
    Cancer Res; 1996 Nov; 56(22):5217-23. PubMed ID: 8912860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.
    Tentori L; Leonetti C; Scarsella M; D'Amati G; Vergati M; Portarena I; Xu W; Kalish V; Zupi G; Zhang J; Graziani G
    Clin Cancer Res; 2003 Nov; 9(14):5370-9. PubMed ID: 14614022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma.
    Storm PB; Renard VM; Moriarity JL; Tyler B; Wilentz RE; Brem H; Weingart JD
    Cancer Chemother Pharmacol; 2004 Oct; 54(4):361-7. PubMed ID: 15197484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frameless stereotactic radiotherapy alone and combined with temozolomide for presumed canine gliomas.
    Dolera M; Malfassi L; Bianchi C; Carrara N; Finesso S; Marcarini S; Mazza G; Pavesi S; Sala M; Urso G
    Vet Comp Oncol; 2018 Mar; 16(1):90-101. PubMed ID: 28643878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.
    Prados MD; Chang SM; Butowski N; DeBoer R; Parvataneni R; Carliner H; Kabuubi P; Ayers-Ringler J; Rabbitt J; Page M; Fedoroff A; Sneed PK; Berger MS; McDermott MW; Parsa AT; Vandenberg S; James CD; Lamborn KR; Stokoe D; Haas-Kogan DA
    J Clin Oncol; 2009 Feb; 27(4):579-84. PubMed ID: 19075262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review.
    Ashby LS; Smith KA; Stea B
    World J Surg Oncol; 2016 Aug; 14(1):225. PubMed ID: 27557526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.